27 August 2018

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

27 August 2018 | n=0


    Display articles in


    Amedeo HIV Infection

    Data Origin

    You selected the following journals for your Amedeo HIV Infection newsletter:

    AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

    To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

    Your email:



    Amedeo HIV Infection

    Five-Week Literature

    25 March 2024

    18 March 2024

    11 March 2024

    04 March 2024

    26 February 2024


    27 August 2018

    Multidisciplinary Journal Club

    1. Emu B, Fessel J, Schrader S, Kumar P, et al.
      Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
      N Engl J Med. 2018;379:645-654.

    2. O'Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, et al.
      Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
      Lancet. 2018 Aug 16. pii: S0140-6736(18)31773.

    3. Arbour KC, Mezquita L, Long N, Rizvi H, et al.
      Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.
      J Clin Oncol. 2018 Aug 20:JCO2018790006. doi: 10.1200/JCO.2018.79.0006.

    Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


    Privacy Policy